Peer-reviewed articles

Girardi F, Di Carlo V, Stiller C, et al. Global survival trends for brain tumors, by histology: Analysis of individual records for 67,776 children diagnosed in 61 countries during 2000–2014 (CONCORD-3). Neuro-Oncology. 2023;25(3):593-606. doi:10.1093/neuonc/noac232

Girardi F, Matz M, Stiller C, et al. Global survival trends for brain tumors, by histology: analysis of individual records for 556,237 adults diagnosed in 59 countries during 2000–2014 (CONCORD-3). Neuro-Oncology. 2023;25(3):580-592. doi:10.1093/neuonc/noac217

Demuru E, Rossi S, Ventura L, et al. Estimating complete cancer prevalence in Europe: validity of alternative vs standard completeness indexes. Front Oncol. 2023;13:1114701. doi:10.3389/fonc.2023.1114701

Cabasag CJ, Arnold M, Rutherford M, et al. Shifting incidence and survival of epithelial ovarian cancer (1995-2014): A SurvMark-2 study. Int J Cancer. 2023;152(9):1763-1777. doi:10.1002/ijc.34403

O’Reilly S, Kathryn Carroll H, Murray D, et al. Impact of the COVID-19 pandemic on cancer care in Ireland - Perspectives from a COVID-19 and Cancer Working Group. J Cancer Policy. 2023;36:100414. doi:10.1016/j.jcpo.2023.100414

Conlon E, Fitzgerald C, Hintze J, et al. High frequency and mortality of head and neck malignancy in organ transplant recipients in Ireland - A national cohort study. Am J Otolaryngol. 2023;44(4):103827. doi:10.1016/j.amjoto.2023.103827

Lopez-Cortes A, Didonè F, Botta L, et al. Cancer data quality and harmonization in Europe: the experience of the BENCHISTA Project – international benchmarking of childhood cancer survival by stage. Front Oncol. 2023;13:1232451. doi:10.3389/fonc.2023.1232451

Matz M, Valkov M, Šekerija M, et al. Worldwide trends in esophageal cancer survival, by sub‐site, morphology, and sex: an analysis of 696,974 adults diagnosed in 60 countries during 2000‐2014 (CONCORD‐3). Cancer Communications. 2023;43(9):963-980. doi:10.1002/cac2.12457

Botta L, Matsuda T, Charvat H, et al. Head and neck cancers survival in Europe, Taiwan, and Japan: results from RARECAREnet Asia based on a privacy-preserving federated infrastructure. Front Oncol. 2023;13:1219111. doi:10.3389/fonc.2023.1219111

Sexton GP, Walsh P, Moriarty F, Lennon P, O’Neill JP. Survival in an era of organ preservation: an update on laryngeal cancer in Ireland. Eur Arch Otorhinolaryngol. 2023;280(10):4587-4595. doi:10.1007/s00405-023-08055-0

McFeely O, Walsh PM, Desmond R, et al. Incidence of cutaneous T-cell lymphoma in the Republic of Ireland between 1994 and 2019. J Eur Acad Dermatol Venereol. 2024;38(2):e145-e147. doi:10.1111/jdv.19497

De Angelis R, Demuru E, Baili P, et al. Complete cancer prevalence in Europe in 2020 by disease duration and country (EUROCARE-6): a population-based study. The Lancet Oncology. 2024;25(3):293-307. doi:10.1016/S1470-2045(23)00646-0

Keogh RJ, Harvey H, Brady C, et al. Dealing with digital paralysis: Surviving a cyberattack in a National Cancer center. J Cancer Policy. 2024;39:100466. doi:10.1016/j.jcpo.2023.100466

Lopez-Cortes A, Didonè F, Botta L, et al. Corrigendum: Cancer data quality and harmonization in Europe: The experience of the BENCHISTA Project – International Benchmarking of Childhood Cancer Survival by Stage. Front Oncol. 2024;14:1397101. doi:10.3389/fonc.2024.1397101

Trama A, Botta L, Stiller C, et al. Survival of European adolescents and young adults diagnosed with cancer in 2010–2014. European Journal of Cancer. 2024;202:113558. doi:10.1016/j.ejca.2024.113558

Sant M, Vener C, Lillini R, et al. Long-term survival for lymphoid neoplasms and national health expenditure (EUROCARE-6): a retrospective, population-based study. The Lancet Oncology. 2024;25(6):731-743. doi:10.1016/S1470-2045(24)00141-4

Sexton GP, Hintze JM, Walsh P, et al. Epidemiology and management of oral cavity squamous cell carcinoma in Ireland. Am J Otolaryngol. 2024;45(3):104235. doi:10.1016/j.amjoto.2024.104235

Millar SR, Mohamed MB, Mykytiv V, et al. Blood Cancer Network Ireland (BCNI) and National Cancer Registry Ireland (NCRI) collaboration: challenges and utility of an Enhanced Blood Cancer Outcomes Registry (EBCOR) pilot. Ir J Med Sci. Published online July 20, 2024. doi:10.1007/s11845-024-03756-9

Botta L, Capocaccia R, Bernasconi A, et al. Estimating cure and risk of death from other causes of cancer patients: EUROCARE-6 data on head & neck, colorectal, and breast cancers. Eur J Cancer. 2024;208:114187. doi:10.1016/j.ejca.2024.114187

Morgan E, O’Neill C, Bardot A, et al. Collecting Long-Term Outcomes in Population-Based Cancer Registry Data: The Case of Breast Cancer Recurrence. JCO Glob Oncol. 2024;10:e2400249. doi:10.1200/GO-24-00249

Bambury N, Zhang M, McCarthy T, et al. Impact of the COVID-19 pandemic on electronic referrals to rapid access clinics for suspected breast, lung and prostate cancers in Ireland. Eur J Public Health. 2024;34(5):908-913. doi:10.1093/eurpub/ckae092

Virgili G, Capocaccia R, Botta L, et al. Survival and Health Care Burden of Children With Retinoblastoma in Europe. JAMA Ophthalmol. 2024;142(11):1062. doi:10.1001/jamaophthalmol.2024.4140

Morgan E, O’Neill C, Shah R, et al. Metastatic recurrence in women diagnosed with non-metastatic breast cancer: a systematic review and meta-analysis. Breast Cancer Res. 2024;26(1):171. doi:10.1186/s13058-024-01881-y

Barrett PM, Daly FP, Zhang M, et al. The impact of the COVID-19 pandemic on the dispensing of systemic anti-cancer therapy (SACT) in Ireland: A population based study. Public Health Pract (Oxf). 2024;8:100557. doi:10.1016/j.puhip.2024.100557

Indini A, Didoné F, Massi D, et al. Incidence and prognosis of cutaneous melanoma in European adolescents and young adults (AYAs): EUROCARE-6 retrospective cohort results. European Journal of Cancer. 2024;213:115079. doi:10.1016/j.ejca.2024.115079